ClearKone® Prescribed to More than 16,000 Patients in 32 Countries

     

    CARLSBAD, Calif., July 22, 2011 — SynergEyes, Inc., the leader in hybrid contact lens technology, announced that ClearKone®, its second generation hybrid contact lens for irregular corneas, has been prescribed to more than 16,000 patients in 32 countries since the lens became available in la…

    (Read More...) 297 views

    New DPS® Throat Spray Can Optimize Immune Support When Used With Del-Immune V® Supplements

     

    Combination of colostrum peptides and Lactobacillus rhamnosus (DV strain) may be pivotal in enabling innate and adaptive immune systems to work together faster and more effectively in fighting illness
    BOULDER, Colo., March 10, 2011 — Pure Research Products, LLC, distributors of Del-Immune V…

    (Read More...) 215 views

    Current Analysis on Cloud Services: New Economic Reality or Futuristic Hype?

     

    STERLING, Va., March 31, 2009 — Managed IT Services delivered through the cloud promise business customers a flexible, cost-effective and, in some cases, technically superior alternative to conventional technology models. Are these services living up to this promise?
    That’s one of th…

    (Read More...) 708 views

    Confirmation of Bogoch Replikins Influenza Patents by Harvard-CDC and Scripps-Crucell Data

     

    BOSTON, March 20, 2009 — Replikins, Ltd. announced today that data recently published from Harvard-CDC and Scripps-Crucell in Nature(1) and Science(2) confirms the 2001 discoveries by Dr. Samuel and Elenore Bogoch of peptides in the hemagglutinin unit of influenza, which they named Replikin…

    (Read More...) 1,180 views

    Discovery Yields Cure for the Common Cold and the Flu

     

    PHOENIX, March 3, 2009 — The cold and flu season is upon us again. This year millions of people in the United States will suffer from the flu and some will even die from it. The latest victim was a young man from Tucson, Arizona. However, this year a small firm in Phoenix, Arizona comes to the rescue. This…

    (Read More...) 1,977 views

    Avidas(TM) Pharmaceuticals Introduces Avidoxy(TM) DK, Simplifying Therapy for Millions Suffering from Severe Acne

     

    DOYLESTOWN, Pa., March 2, 2009 — Avidas(TM) Pharmaceuticals, a privately held, specialty pharmaceutical company which focuses on dermatology, women’s health and endocrinology, today announced the launch of Avidoxy(TM) DK (defence kit), a new patient convenience kit developed to co…

    (Read More...) 915 views